Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Benzydamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | GUCY1B2 | O75343 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CHRM2 | P08172 | 1/20 | 1.00 |
| ▸ | HTR1A | P08908 | 1/20 | 1.00 |
| ▸ | ADRA2A | P08913 | 1/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | CHRM1 | P11229 | 1/20 | 1.00 |
| ▸ | DRD1 | P21728 | 1/20 | 1.00 |
| ▸ | SLC6A2 | P23975 | 1/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 1/20 | 1.00 |
| ▸ | GUCY1A2 | P33402 | 1/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 1/20 | 1.00 |
| ▸ | OPRM1 | P35372 | 1/20 | 1.00 |
| ▸ | DRD3 | P35462 | 1/20 | 1.00 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 1.00 |
| ▸ | GUCY1A1 | Q02108 | 1/20 | 1.00 |
| ▸ | GUCY1B1 | Q02153 | 1/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzydamine SCHEMBL29376229 | 1.00 | HRH3 (1.00) | HRH3KDM4EGUCY1B2CYP1A2CHRM2 | |
| Benzydamine SCHEMBL42644 | 0.99 | POLB (1.00) | HRH3KDM4EGUCY1B2CYP1A2CHRM2 | |
| Benzydamine SCHEMBL42645 | 0.99 | POLB (1.00) | HRH3KDM4EGUCY1B2CYP1A2CHRM2 | |
| Benzydamine SCHEMBL8078518 | 0.99 | HRH3 (0.97) | HRH3KDM4EGUCY1B2CYP1A2CHRM2 | |
| Benzydamine SCHEMBL1648787 | 0.97 | HRH3 (0.95) | HRH3KDM4EGUCY1B2CYP1A2CHRM2 | |
| SCHEMBL8018576 | 0.96 | KDM4E (0.93) | HRH3KDM4EGUCY1B2CYP1A2CHRM2 | |
| SCHEMBL9917397 | 0.94 | DRD1 (0.88) | HRH3KDM4EGUCY1B2CYP1A2CHRM2 | |
| SCHEMBL8810482 | 0.91 | HRH3 (0.84) | HRH3KDM4EGUCY1B2CYP1A2CHRM2 | |
| Benzydamine SCHEMBL7135139 | 0.91 | HRH3 (0.83) | HRH3KDM4EGUCY1B2CYP1A2CHRM2 | |
| Benzydamine SCHEMBL28223703 | 0.91 | HRH3 (0.83) | HRH3KDM4EGUCY1B2CYP1A2CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 8734 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260027337-A1 | TRANSDERMAL DRUG DELIVERY DEVICES AND METHODS | MORNINGSIDE VENTURE INVESTMENTS LTD (MC) | 2026-01-29 | — | — | US | claimed |
| US-12515030-B2 | Transdermal drug delivery devices and methods | MORNINGSIDE VENTURE INVESTMENTS LIMITED (MC) | 2026-01-06 | — | — | US | claimed |
| US-20260000741-A1 | METHOD OF AMELIORATING A PRO-INFLAMMATORY IMMUNOPHENOTYPE IN FARBER DISEASE SUBJECTS BY REPEATED ADMINISTRATION OF A RECOMBINANT HUMAN ACID CERAMIDASE | ACERAGEN INC (US) | 2026-01-01 | — | — | US | claimed |
| US-12427109-B2 | Natural origin stabilizer for oil in water emulsions | FUNDACIÓN CIDETEC (ES) | 2025-09-30 | — | — | US | claimed |
| EP-4615429-A1 | COMPOSITIONS INCLUDING CAFFEIC ACID PHENETHYL ESTER | XMK Therapeutics Inc. (CA) | 2025-09-17 | — | — | EP | claimed |
| EP-4615506-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | Sahin, Fikret (TR) | 2025-09-17 | — | — | EP | claimed |
| US-20250281407-A1 | LIPID DEPOT FORMULATIONS | CAMURUS AB (SE) | 2025-09-11 | — | — | US | claimed |
| US-20250248940-A1 | Biopolymer Formulations for Drug Delivery | 11584022 CANADA INC. (CA) | 2025-08-07 | — | — | US | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| EP-4547280-A1 | BIOPOLYMER FORMULATIONS FOR DRUG DELIVERY | 11584022 Canada Inc. (CA) | 2025-05-07 | — | — | EP | claimed |
| CN-1113149-A | Anti-inflammation medicine and its making method | TIAN SHUYIN (CN) | 1995-12-13 | — | — | CN | claimed |
| WO-1995031194-A1 | COMPOSITIONS FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES | SHAPIRO HOWARD K (US) | 1995-11-23 | — | — | WO | claimed |
| WO-1995023602-A1 | ANTITUSSIVE COMPOSITION CONTAINING AN ANTITUSSIVE AND BENZYDAMINE | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 1995-09-08 | — | — | WO | claimed |
| EP-0650361-A1 | COMPOSITIONS FOR THE TREATMENT OF ARTHRITIS CONTAINING PHOSPHONATES AND NSAIDS | PROCTER & GAMBLE PHARMACEUTICALS, INC. (US) | 1995-05-03 | — | — | EP | claimed |
| WO-1995003799-A1 | USE OF BENZYDAMINE IN THE TREATMENT OF PATHOLOGICAL CONDITIONS CAUSED BY TNF | ANGELINI RICERCHE S.P.A. SOCIETA' CONSORTILE (IT) | 1995-02-09 | — | — | WO | claimed |
| WO-1994000130-A1 | COMPOSITIONS FOR THE TREATMENT OF ARTHRITIS CONTAINING PHOSPHONATES AND NSAIDS | PROCTER & GAMBLE PHARMACEUTICALS, INC. (US) | 1994-01-06 | — | — | WO | claimed |
| CN-1051503-A | Disease and treatment of diseases | NORPHARMCO INC (CA) | 1991-05-22 | — | — | CN | claimed |
| US-4749794-A | REMOVING 1-CHLORO-3-METHYLAMINOPROPANE IMPURITY FROM CRUDE PRODUCT | AZIENDE CHIMICHE RIUNUTE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 1988-06-07 | — | — | US | claimed |
| EP-0195749-A2 | Use of benzydamine in the treatment of the trichomonas vaginalis and gardnerella vaginalis infections | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. (IT) | 1986-09-24 | — | — | EP | claimed |
| US-4211782-A | ANTICOAGULANT, ANTIOXIDANT AND/OR THROMBOXANE A2 SYNTHETASE INHIBITOR | MONCADA SALVADOR (GB) | 1980-07-08 | — | — | US | claimed |